WASHINGTON — Democrats’ drug pricing law will still penalize drugmakers if they hike prices on medicines for patients who have private insurance, a top Medicare official said Thursday.
The penalties may factor into drugmakers’ decisions about how to price their medicines as the new law begins to take effect. Some experts and employers have been concerned that the drug pricing policy reforms that will save money in Medicare could incentivize drugmakers to try to charge more to patients with other forms of insurance coverage.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
